Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
Clinical trial NCT04201574 · COMPLETED
Trial details
- NCT number
- NCT04201574
- Sponsor
- Allysta Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2020-09-15
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.